A groundbreaking pill from Retro Biosciences promises to reverse brain aging and combat dementia. Early human trials show potential to revolutionise Alzheimer's treatment. Discover the science behind this medical marvel.
The UK government has secured 250,000 courses of Merck's molnupiravir, an innovative antiviral pill shown to halve hospitalisations in a major scientific breakthrough.
In a significant setback for British research, pharmaceutical titan Eli Lilly is closing its London research and development hub, putting over 100 jobs at risk and raising concerns about the UK's post-Brexit scientific competitiveness.
A major pharmaceutical multinational has announced a drastic cost-cutting plan, putting 9,000 roles at risk globally. The move signals deepening turmoil within the industry, raising concerns for the UK's strategic life sciences sector.
Danish pharmaceutical giant Novo Nordisk announces major £90 million expansion at its Gatwick facility to meet soaring global demand for its blockbuster diabetes and weight-loss drugs, Ozempic and Wegovy, creating new high-skilled jobs.
Danish pharmaceutical giant Novo Nordisk announces major restructuring, cutting 9,000 jobs globally. The move comes as competition intensifies in the lucrative weight-loss and diabetes drug market, challenging its blockbuster medications Ozempic and Wegov
The Bill & Melinda Gates Foundation announces a major $40m investment in Nigerian and Senegalese vaccine production, aiming to boost Africa's pharmaceutical sovereignty and pandemic resilience.
The incredible story of exenatide, a diabetes medication developed for dogs, that is now revolutionising human weight loss treatments and reshaping our understanding of obesity.
Health Secretary Wes Streeting confronts major pharmaceutical firms, demanding transparency and fair pricing in the NHS's voluntary rebate scheme, which recouped £1.4bn last year.
Pharmaceutical giant Eli Lilly reduces the UK price of its weight-loss drug Mounjaro following backlash, including criticism from former US President Donald Trump.
Robert F. Kennedy Jr cancels plans to develop mRNA vaccines, citing safety concerns and ethical issues. Read the latest updates on this controversial decision.
A new male contraceptive pill shows high efficacy in trials, though some participants reported side effects. Could this revolutionise birth control?
European Union investigates Swiss pharmaceutical firms Roche and Novartis for potential antitrust violations in deals connected to Donald Trump's administration.
Leading European pharmaceutical firms have condemned the Trump administration's new tariffs on medicines, warning they will drive up costs and limit access to vital treatments.
Former US President Donald Trump's proposed tariffs on UK steel exports may be offset by concessions for the British pharmaceutical industry, according to insider reports.
NHS England secures deal to expand access to Orkambi for cystic fibrosis patients after prolonged negotiations with Vertex Pharmaceuticals.